Composition
- Active ingredients
- NEDOSIRAN SODIUM EQ 160MG BASE/ML (EQ 160MG BASE/ML)
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- NEDOSIRAN SODIUM EQ 160MG BASE/ML (EQ 160MG BASE/ML) · SolutionThis page
- NEDOSIRAN SODIUM EQ 80MG BASE/0.5ML (EQ 160MG BASE/ML) · SolutionNDA215842-001 · Prescription
- NEDOSIRAN SODIUM EQ 128MG BASE/0.8ML (EQ 160MG BASE/ML) · SolutionNDA215842-002 · Prescription
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA215842.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Rivfloza
- Active substance
- nedosiran sodium
- Route
- Injection
- Dosage form
- Solution
- Applicant
- Novo
- Status
- Prescription
- FDA approval
- 29 Sept 2023
- Application
- NDA215842-003